Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 1

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis

Total article views   HTML views PDF downloads Totals
4,966 Dovepress* 4,966+ 1,421 6,387
Totals 4,966 1,421 6,387
*Since 15 March 2006
+Since July 2016

View citations on Google Scholar